Market
Averly Health launches in UK to advance cardiometabolic care
Averly Health has launched operations in the UK to expand its cardiometabolic care platform. The move targets conditions including obesity and type 2 diabetes, representing a geographic expansion of the company's digital health offering to a new market.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network